BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10089223)

  • 1. Hormonal regulation of the osteoblastic phenotype expression in neonatal murine calvarial cells.
    Chen TL; Fry D
    Calcif Tissue Int; 1999 Apr; 64(4):304-9. PubMed ID: 10089223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic effects of continuous or discontinuous treatment with dexamethasone and/or calcitriol on osteoblasts differentiated from rat bone marrow stromal cells.
    Atmani H; Audrain C; Mercier L; Chappard D; Basle MF
    J Cell Biochem; 2002; 85(3):640-50. PubMed ID: 11968004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maturation state determines the response of osteogenic cells to surface roughness and 1,25-dihydroxyvitamin D3.
    Lohmann CH; Bonewald LF; Sisk MA; Sylvia VL; Cochran DL; Dean DD; Boyan BD; Schwartz Z
    J Bone Miner Res; 2000 Jun; 15(6):1169-80. PubMed ID: 10841186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dexamethasone, BMP-2, and 1,25-dihydroxyvitamin D enhance a more differentiated osteoblast phenotype: validation of an in vitro model for human bone marrow-derived primary osteoblasts.
    Jørgensen NR; Henriksen Z; Sørensen OH; Civitelli R
    Steroids; 2004 Apr; 69(4):219-26. PubMed ID: 15183687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dexamethasone increases 1,25-dihydroxyvitamin D3 receptor levels and augments bioresponses in rat osteoblast-like cells.
    Chen TL; Hauschka PV; Feldman D
    Endocrinology; 1986 Mar; 118(3):1119-26. PubMed ID: 3004896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dexamethasone and retinoic acid differentially regulate growth and differentiation in an immortalised human clonal bone marrow stromal cell line with osteoblastic characteristics.
    Ogston N; Harrison AJ; Cheung HF; Ashton BA; Hampson G
    Steroids; 2002 Oct; 67(11):895-906. PubMed ID: 12234625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of 1alpha,25-dihydroxy-16ene, 23yne-vitamin D3 on osteoblastic function in human osteosarcoma SaOS-2 cells: differentiation-stage dependence and modulation by 17-beta estradiol.
    Rao LG; Sutherland MK; Reddy GS; Siu-Caldera ML; Uskokovic MR; Murray TM
    Bone; 1996 Dec; 19(6):621-7. PubMed ID: 8968029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Species-specific glucocorticoid and 1,25-dihydroxyvitamin D responsiveness in mouse MC3T3-E1 osteoblasts: dexamethasone inhibits osteoblast differentiation and vitamin D down-regulates osteocalcin gene expression.
    Lian JB; Shalhoub V; Aslam F; Frenkel B; Green J; Hamrah M; Stein GS; Stein JL
    Endocrinology; 1997 May; 138(5):2117-27. PubMed ID: 9112412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucocorticoids promote development of the osteoblast phenotype by selectively modulating expression of cell growth and differentiation associated genes.
    Shalhoub V; Conlon D; Tassinari M; Quinn C; Partridge N; Stein GS; Lian JB
    J Cell Biochem; 1992 Dec; 50(4):425-40. PubMed ID: 1469073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term culture in dexamethasone unmasks an abnormal phenotype in osteoblasts isolated from osteoporotic subjects.
    Rao LG; Murray TM; Wylie JN; McBroom RJ; Sutherland MK
    J Endocrinol Invest; 2005 Nov; 28(10):919-27. PubMed ID: 16419495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexamethasone enhances the osteogenic effects of fluoride in human TE85 osteosarcoma cells in vitro.
    Takada J; Chevalley T; Baylink DJ; Lau KH
    Calcif Tissue Int; 1996 May; 58(5):355-61. PubMed ID: 8661971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical localization of the estrogen receptor in human osteoblastic SaOS-2 cells: association of receptor levels with alkaline phosphatase activity.
    Sutherland MK; Hui DU; Rao LG; Wylie JN; Murray TM
    Bone; 1996 Apr; 18(4):361-9. PubMed ID: 8726395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human and murine osteocalcin gene expression: conserved tissue restricted expression and divergent responses to 1,25-dihydroxyvitamin D3 in vivo.
    Sims NA; White CP; Sunn KL; Thomas GP; Drummond ML; Morrison NA; Eisman JA; Gardiner EM
    Mol Endocrinol; 1997 Oct; 11(11):1695-708. PubMed ID: 9328351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and regulation of galectin 3 in rat osteoblastic cells.
    Aubin JE; Gupta AK; Bhargava U; Turksen K
    J Cell Physiol; 1996 Dec; 169(3):468-80. PubMed ID: 8952696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The biological activities of 1alpha,25-dihydroxyvitamin D3 and its synthetic analog 1alpha,25-dihydroxy-16-ene-vitamin D3 in normal human osteoblastic cells and human osteosarcoma SaOS-2 cells are modulated by 17-beta estradiol and dependent on stage of differentiation.
    Rao LG; Liu LJ; Rawlins MR; McBroom RJ; Murray TM; Reddy GS; Uskokovic MR; Rao DS; Sutherland MK
    Biol Pharm Bull; 2001 Mar; 24(3):242-8. PubMed ID: 11256478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The frequency of common progenitors for adipocytes and osteoblasts and of committed and restricted adipocyte and osteoblast progenitors in fetal rat calvaria cell populations.
    Bellows CG; Heersche JN
    J Bone Miner Res; 2001 Nov; 16(11):1983-93. PubMed ID: 11697794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotype-associated changes in the effects of 1,25-dihydroxyvitamin D3 on alkaline phosphatase and bone GLA-protein of rat osteoblastic cells.
    Spiess YH; Price PA; Deftos JL; Manolagas SC
    Endocrinology; 1986 Apr; 118(4):1340-6. PubMed ID: 3485045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A highly potent 26,27-Hexafluoro-1a,25-dihydroxyvitamin D3 on calcification in SV40-transformed human fetal osteoblastic cells.
    Miyahara T; Simoura T; Osahune N; Uchida Y; Sakuma T; Nemoto N; Kozakai A; Takamura T; Yamazaki R; Higuchi S; Chiba H; Iba K; Sawada N
    Calcif Tissue Int; 2002 Jun; 70(6):488-95. PubMed ID: 12016462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mouse embryo-derived NIH3T3 fibroblasts adopt an osteoblast-like phenotype when treated with 1alpha,25-dihydroxyvitamin D(3) and dexamethasone in vitro.
    Shui C; Scutt AM
    J Cell Physiol; 2002 Nov; 193(2):164-72. PubMed ID: 12384993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developmental stage-specific cellular responses to vitamin D and glucocorticoids during differentiation of the osteoblast phenotype: interrelationship of morphology and gene expression by in situ hybridization.
    Pockwinse SM; Stein JL; Lian JB; Stein GS
    Exp Cell Res; 1995 Jan; 216(1):244-60. PubMed ID: 7813627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.